무균 시험 시장 : 시장 규모, 점유율, 성장, 산업 분석 = 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of sterility testing Market

The global sterility testing market was valued at USD 1.28 billion in 2025 and is projected to grow to USD 1.38 billion in 2026, ultimately reaching USD 2.63 billion by 2034, exhibiting a CAGR of 8.4% during the forecast period. North America dominated the market in 2025, accounting for a 39.79% share, driven by extensive pharmaceutical production, strict regulatory frameworks, and technological advancements in sterility assurance.

Sterility testing is a crucial quality control process used in pharmaceuticals, biopharmaceuticals, and medical devices to ensure products are free from harmful microorganisms. The market is witnessing robust growth due to increasing biologics production, vaccines, combination products, rising regulatory emphasis on contamination prevention, and the growing adoption of rapid microbiological methods (RMMs). Key industry players such as Merck KGaA, Sartorius AG, SKAN AG, Getinge AB, and Fedegari Autoclavi S.p.A. are driving market expansion through product innovations and strategic investments.

Market Dynamics

Market Drivers

Rising Biologics Complexity and Stringent Safety Regulations

The demand for sterility testing is propelled by the increasing complexity of sterile manufacturing processes. Advanced therapies like biologics, vaccines, and ATMPs necessitate validated methods, media fills, isolator systems, and robust contamination control. Contract development and manufacturing organizations (CDMOs) are expanding capacities and implementing rapid testing methods to accelerate product release. For example, in October 2025, Eli Lilly announced over USD 1 billion investment to expand its production facility in India, supporting stricter sterility requirements.

Market Restraints

Limited Standardization and Complex Validation Procedures

Lack of globally harmonized sterility testing protocols poses challenges for manufacturers. Regulatory variations among USP, EP, and JP result in redundant validation efforts, increased costs, and delayed product release. Rapid microbiological methods require extensive equivalence and comparability studies, further complicating compliance. For instance, Brassica Pharma received an FDA warning in July 2024 for GMP violations, highlighting these challenges.

Market Opportunities

Adoption of Rapid Microbiological Methods

RMMs, including flow cytometry, molecular assays, and automated growth-based systems, are revolutionizing sterility testing by reducing timelines from weeks to days while maintaining accuracy. Integration of isolator robotics, closed-loop sampling, and electronic batch records further improves efficiency. For example, in September 2025, Nelson Laboratories, LLC launched RapidCert, combining RMMs with traditional biological indicators, offering faster and reliable sterility testing solutions.

Market Trends

Increasing Outsourcing of Sterility Testing Services

Pharmaceutical and biotech companies are increasingly outsourcing sterility testing to specialized CDMOs and contract labs to reduce operational costs and leverage advanced technologies. Strategic collaborations, such as the one between MRPC and Vance Street Capital in October 2025, reflect the growing reliance on external testing services.

Market Challenges

Shortage of Skilled Microbiologists

A significant challenge is the lack of qualified professionals trained in aseptic handling, isolator operations, and RMM validation. Regions with limited training infrastructure face difficulties retaining skilled staff, contributing to workflow inefficiencies and compliance risks. The Skill India Report 2024 highlighted a 37% employability rate in pharmaceutical quality control, below the national average of 46%.

Segmentation Analysis

By Type

The services segment held the largest share in 2026 at 55.69%, driven by strict regulatory requirements and the growing trend of outsourcing. Kits & reagents and instruments are also witnessing growth, with kits & reagents expected to grow at a CAGR of 7.1%.

By Test Type

Membrane filtration systems dominated in 2025 and are expected to maintain leadership in 2026 with 66.82% share, due to wide adoption and compliance with pharmacopeial standards.

By Site

The outsourced testing segment led the market in 2025, with 56.18% share in 2026, driven by high costs of in-house isolator-equipped cleanrooms and skilled workforce shortages.

By Application

The pharmaceutical sector dominated in 2025 and is expected to hold 71.92% share in 2026, driven by biologics, biosimilars, and ATMP production, which demand extensive sterility testing.

By End User

Pharma & biotech manufacturers led the market in 2024 and continue to drive growth due to high production volumes and strict validation requirements. CDMOs/CMOs are projected to grow at a CAGR of 8.8%.

Regional Outlook

North America held the largest share in 2025 at USD 0.51 billion and maintained leadership in 2026 at USD 0.55 billion. Europe reached USD 0.40 billion in 2025, while Asia Pacific was USD 0.25 billion in 2025 and is expected to register the fastest CAGR due to increasing pharmaceutical production and regulatory investments. Latin America and Middle East & Africa recorded USD 0.07 billion and USD 0.03 billion respectively in 2025.

Competitive Landscape

The market is semi-consolidated, dominated by Merck KGaA, Sartorius AG, SKAN AG, Getinge AB, and Fedegari Autoclavi S.p.A., focusing on strategic partnerships, product innovations, and geographic expansion. Other key players include Charles River Laboratories, Thermo Fisher Scientific, Hardy Diagnostics, and Danaher. Strategic collaborations and investments in rapid microbiological methods are central to maintaining competitive advantage.

Conclusion

The global sterility testing market is projected to grow from USD 1.38 billion in 2026 to USD 2.63 billion by 2034 at a CAGR of 8.4%. North America remains the dominant region, supported by advanced pharmaceutical production, regulatory compliance, and technology adoption, while Asia Pacific emerges as the fastest-growing market. Market growth is driven by biologics complexity, rapid microbiological methods, and the trend toward outsourcing testing services. Despite challenges like skilled labor shortages and complex validation procedures, innovations in automated sterility testing and strategic collaborations are expected to sustain robust growth through 2034.

Segmentation By Type, Test Type, Site, Application, End User, and Region

By Type * Kits & Reagents

• Instruments
• Services

By Test Type * Membrane Filtration Systems

• Incubation and Monitoring Systems
• Others

By Site * In-House Testing

• Outsourced Testing

By Application * Pharmaceuticals

• Medical Devices
• Others

By End User * Pharma & Biotech Manufacturers

• Medical Device Manufacturers
• CDMOs/CMOs & Contract Testing Labs
• Others

By Geography * North America (By Type, Test Type, Site, Application, End User, and Country)

• U.S.
  • By Type
• Canada
  • By Type
• Europe (By Type, Test Type, Site, Application, End User, and Country/Sub-region)
  • Germany
    • By Type
  • U.K.
    • By Type
  • France
    • By Type
  • Spain
    • By Type
  • Italy
    • By Type
  • Scandinavia
    • By Type
  • Rest of Europe
    • By Type
• Asia Pacific (By Type, Test Type, Site, Application, End User, and Country/Sub-region)
  • China
    • By Type
  • Japan
    • By Type
  • India
    • By Type
  • Australia
    • By Type
  • Southeast Asia
    • By Type
  • Rest of Asia Pacific
    • By Type
• Latin America (By Type, Test Type, Site, Application, End User, and Country/Sub-region)
  • Brazil
    • By Type
  • Mexico
    • By Type
  • Rest of Latin America
    • By Product Type
• Middle East and Africa (By Type, Test Type, Site, Application, End User, and Country/Sub-region)
  • GCC
    • By Type
  • Saudi Arabia
    • By Type
  • Rest of Middle East and Africa
    • By Type

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2026
• 4.2. Technological Advancements in Sterility Testing
• 4.3. New Product Launches, Key Players
• 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Kits & Reagents
  • 5.1.2. Instruments
  • 5.1.3. Services
• 5.2. Market Analysis, Insights and Forecast - By Test Type
  • 5.2.1. Membrane Filtration Systems
  • 5.2.2. Incubation and Monitoring Systems
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Site
  • 5.3.1. In-House Testing
  • 5.3.2. Outsourced Testing
• 5.4. Market Analysis, Insights and Forecast - By Application
  • 5.4.1. Pharmaceuticals
  • 5.4.2. Medical Devices
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By End-user
  • 5.5.1. Pharma & Biotech Manufacturers
  • 5.5.2. Medical Device Manufacturers
  • 5.5.3. CDMOs/CMOs & Contract Testing Labs
  • 5.5.4. Others
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East and Africa

6. North America Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Kits & Reagents
  • 6.1.2. Instruments
  • 6.1.3. Services
• 6.2. Market Analysis, Insights and Forecast - By Test Type
  • 6.2.1. Membrane Filtration Systems
  • 6.2.2. Incubation and Monitoring Systems
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Site
  • 6.3.1. In-House Testing
  • 6.3.2. Outsourced Testing
• 6.4. Market Analysis, Insights and Forecast - By Application
  • 6.4.1. Pharmaceuticals
  • 6.4.2. Medical Devices
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By End-user
  • 6.5.1. Pharma & Biotech Manufacturers
  • 6.5.2. Medical Device Manufacturers
  • 6.5.3. CDMOs/CMOs & Contract Testing Labs
  • 6.5.4. Others
• 6.6. Market Analysis, Insights and Forecast - By Country
  • 6.6.1. U.S.
    • 6.6.1.1. By Type
  • 6.6.2. Canada
    • 6.6.2.1. By Type

7. Europe Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Kits & Reagents
  • 7.1.2. Instruments
  • 7.1.3. Services
• 7.2. Market Analysis, Insights and Forecast - By Test Type
  • 7.2.1. Membrane Filtration Systems
  • 7.2.2. Incubation and Monitoring Systems
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Site
  • 7.3.1. In-House Testing
  • 7.3.2. Outsourced Testing
• 7.4. Market Analysis, Insights and Forecast - By Application
  • 7.4.1. Pharmaceuticals
  • 7.4.2. Medical Devices
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By End-user
  • 7.5.1. Pharma & Biotech Manufacturers
  • 7.5.2. Medical Device Manufacturers
  • 7.5.3. CDMOs/CMOs & Contract Testing Labs
  • 7.5.4. Others
• 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.6.1. U.K.
    • 7.6.1.1. By Type
  • 7.6.2. Germany
    • 7.6.2.1. By Type
  • 7.6.3. France
    • 7.6.3.1. By Type
  • 7.6.4. Spain
    • 7.6.4.1. By Type
  • 7.6.5. Italy
    • 7.6.5.1. By Type
  • 7.6.6. Scandinavia
    • 7.6.6.1. By Type
  • 7.6.7. Rest of Europe
    • 7.6.7.1. By Type

8. Asia Pacific Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Kits & Reagents
  • 8.1.2. Instruments
  • 8.1.3. Services
• 8.2. Market Analysis, Insights and Forecast - By Test Type
  • 8.2.1. Membrane Filtration Systems
  • 8.2.2. Incubation and Monitoring Systems
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Site
  • 8.3.1. In-House Testing
  • 8.3.2. Outsourced Testing
• 8.4. Market Analysis, Insights and Forecast - By Application
  • 8.4.1. Pharmaceuticals
  • 8.4.2. Medical Devices
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By End-user
  • 8.5.1. Pharma & Biotech Manufacturers
  • 8.5.2. Medical Device Manufacturers
  • 8.5.3. CDMOs/CMOs & Contract Testing Labs
  • 8.5.4. Others
• 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.6.1. Japan
    • 8.6.1.1. By Type
  • 8.6.2. Australia
    • 8.6.2.1. By Type
  • 8.6.3. China
    • 8.6.3.1. By Type
  • 8.6.4. India
    • 8.6.4.1. By Type
  • 8.6.5. Southeast Asia
    • 8.6.5.1. By Type
  • 8.6.6. Rest of Asia Pacific
    • 8.6.6.1. By Type

9. Latin America Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Kits & Reagents
  • 9.1.2. Instruments
  • 9.1.3. Services
• 9.2. Market Analysis, Insights and Forecast - By Test Type
  • 9.2.1. Membrane Filtration Systems
  • 9.2.2. Incubation and Monitoring Systems
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Site
  • 9.3.1. In-House Testing
  • 9.3.2. Outsourced Testing
• 9.4. Market Analysis, Insights and Forecast - By Application
  • 9.4.1. Pharmaceuticals
  • 9.4.2. Medical Devices
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By End-user
  • 9.5.1. Pharma & Biotech Manufacturers
  • 9.5.2. Medical Device Manufacturers
  • 9.5.3. CDMOs/CMOs & Contract Testing Labs
  • 9.5.4. Others
• 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.6.1. Brazil
    • 9.6.1.1. By Type
  • 9.6.2. Mexico
    • 9.6.2.1. By Type
  • 9.6.3. Rest of Latin America
    • 9.6.3.1. By Type

10. Middle East and Africa Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Kits & Reagents
  • 10.1.2. Instruments
  • 10.1.3. Services
• 10.2. Market Analysis, Insights and Forecast - By Test Type
  • 10.2.1. Membrane Filtration Systems
  • 10.2.2. Incubation and Monitoring Systems
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Site
  • 10.3.1. In-House Testing
  • 10.3.2. Outsourced Testing
• 10.4. Market Analysis, Insights and Forecast - By Application
  • 10.4.1. Pharmaceuticals
  • 10.4.2. Medical Devices
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By End-user
  • 10.5.1. Pharma & Biotech Manufacturers
  • 10.5.2. Medical Device Manufacturers
  • 10.5.3. CDMOs/CMOs & Contract Testing Labs
  • 10.5.4. Others
• 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.6.1. South Africa
    • 10.6.1.1. By Type
  • 10.6.2. GCC
    • 10.6.2.1. By Type
  • 10.6.3. Rest of Middle East and Africa
    • 10.6.3.1. By Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2026)
• 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
  • 11.2.1. Merck KGaA
  • 11.2.2. Sartorius AG
  • 11.2.3. SKAN AG
  • 11.2.4. Getinge AB
  • 11.2.5. Fedegari Autoclavi S.p.A.
  • 11.2.6. Extract Technology Limited
  • 11.2.7. bioMerieux SA
  • 11.2.8. Charles River Laboratories International, Inc.
  • 11.2.9. Thermo Fisher Scientific Inc.
  • 11.2.10. Hardy Diagnostics
  • 11.2.11. Danaher